Europe Parkinson's Disease Treatment Industry Market Research Report

SKU ID :Maia-15119179 | Published Date: 23-Jan-2020 | No. of pages: 105
1 Parkinson's Disease Treatment Introduction and Market Overview 1.1 Objectives of the Study 1.2 Definition of Parkinson's Disease Treatment 1.3 Parkinson's Disease Treatment Market Scope and Market Size Estimation 1.3.1 Market Concentration Ratio and Market Maturity Analysis 1.3.2 Europe Parkinson's Disease Treatment Value and Growth Rate from 2014-2024 1.4 Market Segmentation 1.4.1 Types of Parkinson's Disease Treatment 1.4.2 Applications of Parkinson's Disease Treatment 1.4.3 Research Countries 1.5 Market Dynamics 1.5.1 Drivers 1.5.2 Limitations 1.5.3 Opportunities 1.6 Industry News and Policies by Countries 1.6.1 Industry News 1.6.2 Industry Policies 2 Industry Chain Analysis 2.1 Upstream Raw Material Suppliers of Parkinson's Disease Treatment Analysis 2.2 Major Players of Parkinson's Disease Treatment 2.2.1 Major Players Manufacturing Base and Market Share of Parkinson's Disease Treatment in 2018 2.2.2 Major Players Product Types in 2018 2.3 Parkinson's Disease Treatment Manufacturing Cost Structure Analysis 2.3.1 Consumption Process Analysis 2.3.2 Manufacturing Cost Structure of Parkinson's Disease Treatment 2.3.3 Raw Material Cost of Parkinson's Disease Treatment 2.3.4 Labor Cost of Parkinson's Disease Treatment 2.4 Market Channel Analysis of Parkinson's Disease Treatment 2.5 Major Downstream Buyers of Parkinson's Disease Treatment Analysis 3 Europe Parkinson's Disease Treatment Market, by Type 3.1 Europe Parkinson's Disease Treatment Value and Market Share by Type (2014-2019E) 3.2 Europe Parkinson's Disease Treatment Consumption and Market Share by Type (2014-2019E) 3.3 Europe Parkinson's Disease Treatment Value and Growth Rate by Type (2014-2019E) 3.3.1 Europe Parkinson's Disease Treatment Value and Growth Rate of Levodopa 3.3.2 Europe Parkinson's Disease Treatment Value and Growth Rate of Selegiline 3.3.3 Europe Parkinson's Disease Treatment Value and Growth Rate of Dopamine Antagonists 3.3.4 Europe Parkinson's Disease Treatment Value and Growth Rate of Others 3.4 Europe Parkinson's Disease Treatment Price Analysis by Type (2014-2019E) 4 Parkinson's Disease Treatment Market, by Application 4.1 Downstream Market Overview 4.2 Europe Parkinson's Disease Treatment Consumption and Market Share by Application (2014-2019E) 4.2.1 Europe Parkinson's Disease Treatment Consumption and Growth Rate of Hospitals (2014-2019E) 4.2.2 Europe Parkinson's Disease Treatment Consumption and Growth Rate of Clinics (2014-2019E) 5 Europe Parkinson's Disease Treatment Consumption, Value ($) by Countries (2014-2019E) 5.1 Europe Parkinson's Disease Treatment Value and Market Share by Countries (2014-2019E) 5.2 Europe Parkinson's Disease Treatment Consumption and Market Share by Countries (2014-2019E) 5.3 Europe Parkinson's Disease Treatment Consumption, Value, Price and Gross Margin (2014-2019E) 5.4 Germany Parkinson's Disease Treatment Consumption, Value, Price and Gross Margin (2014-2019E) 5.5 UK Parkinson's Disease Treatment Consumption, Value, Price and Gross Margin (2014-2019E) 5.6 France Parkinson's Disease Treatment Consumption, Value, Price and Gross Margin (2014-2019E) 5.7 Italy Parkinson's Disease Treatment Consumption, Value, Price and Gross Margin (2014-2019E) 5.8 Spain Parkinson's Disease Treatment Consumption, Value, Price and Gross Margin (2014-2019E) 5.9 Russia Parkinson's Disease Treatment Consumption, Value, Price and Gross Margin (2014-2019E) 6 Competitive Landscape 6.1 Competitive Profile 6.2 UCB (Belgium) 6.2.1 Company Profiles 6.2.2 Parkinson's Disease Treatment Product Introduction 6.2.3 UCB (Belgium) Sales, Value, Price, Gross Margin 2014-2019E 6.2.4 UCB (Belgium) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 6.3 Valeant Pharmaceuticals (Canada) 6.3.1 Company Profiles 6.3.2 Parkinson's Disease Treatment Product Introduction 6.3.3 Valeant Pharmaceuticals (Canada) Sales, Value, Price, Gross Margin 2014-2019E 6.3.4 Valeant Pharmaceuticals (Canada) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 6.4 Lundbeck (Denmark) 6.4.1 Company Profiles 6.4.2 Parkinson's Disease Treatment Product Introduction 6.4.3 Lundbeck (Denmark) Sales, Value, Price, Gross Margin 2014-2019E 6.4.4 Lundbeck (Denmark) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 6.5 Boehringer Ingelheim (Germany) 6.5.1 Company Profiles 6.5.2 Parkinson's Disease Treatment Product Introduction 6.5.3 Boehringer Ingelheim (Germany) Sales, Value, Price, Gross Margin 2014-2019E 6.5.4 Boehringer Ingelheim (Germany) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 6.6 Wockhardt (India) 6.6.1 Company Profiles 6.6.2 Parkinson's Disease Treatment Product Introduction 6.6.3 Wockhardt (India) Sales, Value, Price, Gross Margin 2014-2019E 6.6.4 Wockhardt (India) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 6.7 Merck (US) 6.7.1 Company Profiles 6.7.2 Parkinson's Disease Treatment Product Introduction 6.7.3 Merck (US) Sales, Value, Price, Gross Margin 2014-2019E 6.7.4 Merck (US) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 6.8 Acadia (US) 6.8.1 Company Profiles 6.8.2 Parkinson's Disease Treatment Product Introduction 6.8.3 Acadia (US) Sales, Value, Price, Gross Margin 2014-2019E 6.8.4 Acadia (US) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 6.9 Sun Pharma (India) 6.9.1 Company Profiles 6.9.2 Parkinson's Disease Treatment Product Introduction 6.9.3 Sun Pharma (India) Sales, Value, Price, Gross Margin 2014-2019E 6.9.4 Sun Pharma (India) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 6.10 Novartis AG (Switzerland) 6.10.1 Company Profiles 6.10.2 Parkinson's Disease Treatment Product Introduction 6.10.3 Novartis AG (Switzerland) Sales, Value, Price, Gross Margin 2014-2019E 6.10.4 Novartis AG (Switzerland) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 6.11 GSK (UK) 6.11.1 Company Profiles 6.11.2 Parkinson's Disease Treatment Product Introduction 6.11.3 GSK (UK) Sales, Value, Price, Gross Margin 2014-2019E 6.11.4 GSK (UK) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 6.12 Teva (Israel) 6.12.1 Company Profiles 6.12.2 Parkinson's Disease Treatment Product Introduction 6.12.3 Teva (Israel) Sales, Value, Price, Gross Margin 2014-2019E 6.12.4 Teva (Israel) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 6.13 Impax Laboratories (US) 6.13.1 Company Profiles 6.13.2 Parkinson's Disease Treatment Product Introduction 6.13.3 Impax Laboratories (US) Sales, Value, Price, Gross Margin 2014-2019E 6.13.4 Impax Laboratories (US) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 6.14 AbbVie (US) 6.14.1 Company Profiles 6.14.2 Parkinson's Disease Treatment Product Introduction 6.14.3 AbbVie (US) Sales, Value, Price, Gross Margin 2014-2019E 6.14.4 AbbVie (US) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 7 Europe Parkinson's Disease Treatment Market Analysis and Forecast by Type and Application 7.1 Europe Parkinson's Disease Treatment Market Value & Volume Forecast, by Type (2019-2024) 7.1.1 Levodopa Market Value and Volume Forecast (2019-2024) 7.1.2 Selegiline Market Value and Volume Forecast (2019-2024) 7.1.3 Dopamine Antagonists Market Value and Volume Forecast (2019-2024) 7.1.4 Others Market Value and Volume Forecast (2019-2024) 7.2 Europe Parkinson's Disease Treatment Market Value & Volume Forecast, by Application (2019-2024) 7.2.1 Hospitals Market Value and Volume Forecast (2019-2024) 7.2.2 Clinics Market Value and Volume Forecast (2019-2024) 8 Parkinson's Disease Treatment Market Analysis and Forecast by Countries 8.1 Germany Market Value and Consumption Forecast (2019-2024) 8.2 UK Market Value and Consumption Forecast (2019-2024) 8.3 France Market Value and Consumption Forecast (2019-2024) 8.4 Italy Market Value and Consumption Forecast (2019-2024) 8.5 Spain Market Value and Consumption Forecast (2019-2024) 8.6 Russia Market Value and Consumption Forecast (2019-2024) 9 New Project Feasibility Analysis 9.1 Industry Barriers and New Entrants SWOT Analysis 9.2 Analysis and Suggestions on New Project Investment 10 Research Finding and Conclusion 11 Appendix 11.1 Methodology 11.2 Research Data Source
List of Tables and Figures Figure Product Picture of Parkinson's Disease Treatment Table Product Specification of Parkinson's Disease Treatment Figure Market Concentration Ratio and Market Maturity Analysis of Parkinson's Disease Treatment Figure Europe Parkinson's Disease Treatment Value ($) and Growth Rate from 2014-2024 Table Different Types of Parkinson's Disease Treatment Figure Europe Parkinson's Disease Treatment Value ($) Segment by Type from 2014-2019E Figure Europe Parkinson's Disease Treatment Market Share by Types in 2018 Figure Levodopa Picture Figure Selegiline Picture Figure Dopamine Antagonists Picture Figure Others Picture Table Different Applications of Parkinson's Disease Treatment Figure Europe Parkinson's Disease Treatment Value ($) Segment by Applications from 2014-2019E Figure Europe Parkinson's Disease Treatment Market Share by Applications in 2018 Figure Hospitals Picture Figure Clinics Picture Table Research Countries of Parkinson's Disease Treatment Figure Europe Parkinson's Disease Treatment Market Share by Countries in 2018 Figure Germany Parkinson's Disease Treatment Consumption Value ($) and Growth Rate (2014-2019E) Figure UK Parkinson's Disease Treatment Consumption Value ($) and Growth Rate (2014-2019E) Figure France Parkinson's Disease Treatment Consumption Value ($) and Growth Rate (2014-2019E) Figure Italy Parkinson's Disease Treatment Consumption Value ($) and Growth Rate (2014-2019E) Figure Spain Parkinson's Disease Treatment Consumption Value ($) and Growth Rate (2014-2019E) Figure Russia Parkinson's Disease Treatment Consumption Value ($) and Growth Rate (2014-2019E) Table Emerging and Growing Market of Parkinson's Disease Treatment Table Industry News Table Industry Policies Figure Industry Chain Analysis of Parkinson's Disease Treatment Table Upstream Raw Material Suppliers of Parkinson's Disease Treatment with Contact Information Table Major Players Manufacturing Base and Market Share of Parkinson's Disease Treatment in 2018 Table Major Players Consumption Value Market Share of Parkinson's Disease Treatment in 2018 Table Major Players Parkinson's Disease Treatment Product Types in 2018 Figure Consumption Process of Parkinson's Disease Treatment Figure Manufacturing Cost Structure of Parkinson's Disease Treatment Figure Channel Status of Parkinson's Disease Treatment Table Major Distributors of Parkinson's Disease Treatment with Contact Information Table Major Downstream Buyers of Parkinson's Disease Treatment with Contact Information Table Europe Parkinson's Disease Treatment Value ($) by Type (2014-2019E) Table Europe Parkinson's Disease Treatment Value Share by Type (2014-2019E) Figure Europe Parkinson's Disease Treatment Value Share by Type (2014-2019E) Table Europe Parkinson's Disease Treatment Consumption by Type (2014-2019E) Table Europe Parkinson's Disease Treatment Consumption Share by Type (2014-2019E) Figure Europe Parkinson's Disease Treatment Consumption Share by Type (2014-2019E) Figure Levodopa Picture Figure Selegiline Picture Figure Dopamine Antagonists Picture Figure Others Picture Figure Europe Parkinson's Disease Treatment Value ($) and Growth Rate of Others Table Europe Parkinson's Disease Treatment Price by Type (2014-2019E) Figure Downstream Market Overview Table Europe Parkinson's Disease Treatment Consumption by Application (2014-2019E) Table Europe Parkinson's Disease Treatment Consumption Market Share by Application (2014-2019E) Figure Europe Parkinson's Disease Treatment Consumption Market Share by Application (2014-2019E) Figure Europe Parkinson's Disease Treatment Consumption and Growth Rate of Hospitals (2014-2019) Figure Europe Parkinson's Disease Treatment Consumption and Growth Rate of Clinics (2014-2019) Table Europe Parkinson's Disease Treatment Value ($) by Countries (2014-2019E) Table Europe Parkinson's Disease Treatment Value Market Share by Countries (2014-2019E) Figure Europe Parkinson's Disease Treatment Value Market Share by Countries (2014-2019E) Table Europe Parkinson's Disease Treatment Consumption by Countries (2014-2019E) Table Europe Parkinson's Disease Treatment Consumption Market Share by Countries (2014-2019E) Figure Europe Parkinson's Disease Treatment Consumption Market Share by Countries (2014-2019E) Table Europe Parkinson's Disease Treatment Consumption, Value, Price and Gross Margin (2014-2019E) Table Germany Parkinson's Disease Treatment Consumption, Value, Price and Gross Margin (2014-2019E) Table UK Parkinson's Disease Treatment Consumption, Value, Price and Gross Margin (2014-2019E) Table France Parkinson's Disease Treatment Consumption, Value, Price and Gross Margin (2014-2019E) Table Italy Parkinson's Disease Treatment Consumption, Value, Price and Gross Margin (2014-2019E) Table Spain Parkinson's Disease Treatment Consumption, Value, Price and Gross Margin (2014-2019E) Table Russia Parkinson's Disease Treatment Consumption, Value, Price and Gross Margin (2014-2019E) Figure Top 3 Market Share of Parkinson's Disease Treatment Companies in 2018 Figure Top 6 Market Share of Parkinson's Disease Treatment Companies in 2018 Table Major Players Value ($) Share (2014-2019E) Table Company Profiles Table Product Introduction Table UCB (Belgium) Sales, Value, Price, Gross Margin 2014-2019E Figure UCB (Belgium) Sales and Growth Rate Figure UCB (Belgium) Value ($) Market Share 2014-2019 Figure UCB (Belgium) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Valeant Pharmaceuticals (Canada) Sales, Value, Price, Gross Margin 2014-2019E Figure Valeant Pharmaceuticals (Canada) Sales and Growth Rate Figure Valeant Pharmaceuticals (Canada) Value ($) Market Share 2014-2019 Figure Valeant Pharmaceuticals (Canada) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Lundbeck (Denmark) Sales, Value, Price, Gross Margin 2014-2019E Figure Lundbeck (Denmark) Sales and Growth Rate Figure Lundbeck (Denmark) Value ($) Market Share 2014-2019 Figure Lundbeck (Denmark) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Boehringer Ingelheim (Germany) Sales, Value, Price, Gross Margin 2014-2019E Figure Boehringer Ingelheim (Germany) Sales and Growth Rate Figure Boehringer Ingelheim (Germany) Value ($) Market Share 2014-2019 Figure Boehringer Ingelheim (Germany) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Wockhardt (India) Sales, Value, Price, Gross Margin 2014-2019E Figure Wockhardt (India) Sales and Growth Rate Figure Wockhardt (India) Value ($) Market Share 2014-2019 Figure Wockhardt (India) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Merck (US) Sales, Value, Price, Gross Margin 2014-2019E Figure Merck (US) Sales and Growth Rate Figure Merck (US) Value ($) Market Share 2014-2019 Figure Merck (US) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Acadia (US) Sales, Value, Price, Gross Margin 2014-2019E Figure Acadia (US) Sales and Growth Rate Figure Acadia (US) Value ($) Market Share 2014-2019 Figure Acadia (US) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Sun Pharma (India) Sales, Value, Price, Gross Margin 2014-2019E Figure Sun Pharma (India) Sales and Growth Rate Figure Sun Pharma (India) Value ($) Market Share 2014-2019 Figure Sun Pharma (India) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Novartis AG (Switzerland) Sales, Value, Price, Gross Margin 2014-2019E Figure Novartis AG (Switzerland) Sales and Growth Rate Figure Novartis AG (Switzerland) Value ($) Market Share 2014-2019 Figure Novartis AG (Switzerland) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table GSK (UK) Sales, Value, Price, Gross Margin 2014-2019E Figure GSK (UK) Sales and Growth Rate Figure GSK (UK) Value ($) Market Share 2014-2019 Figure GSK (UK) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Teva (Israel) Sales, Value, Price, Gross Margin 2014-2019E Figure Teva (Israel) Sales and Growth Rate Figure Teva (Israel) Value ($) Market Share 2014-2019 Figure Teva (Israel) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table Impax Laboratories (US) Sales, Value, Price, Gross Margin 2014-2019E Figure Impax Laboratories (US) Sales and Growth Rate Figure Impax Laboratories (US) Value ($) Market Share 2014-2019 Figure Impax Laboratories (US) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 Table Company Profiles Table Product Introduction Table AbbVie (US) Sales, Value, Price, Gross Margin 2014-2019E Figure AbbVie (US) Sales and Growth Rate Figure AbbVie (US) Value ($) Market Share 2014-2019 Figure AbbVie (US) Market Share of Parkinson's Disease Treatment Segmented by Region in 2018 Table Europe Parkinson's Disease Treatment Market Value ($) Forecast, by Type Table Europe Parkinson's Disease Treatment Market Volume Forecast, by Type Table Europe Market Value ($) Forecast by Application (2019-2024) Table Europe Market Volume Forecast by Application (2019-2024) Figure Germany Market Value ($) and Growth Rate Forecast (2019-2024) Figure Germany Consumption and Growth Rate Forecast (2019-2024) Figure UK Market Value ($) and Growth Rate Forecast (2019-2024) Figure UK Consumption and Growth Rate Forecast (2019-2024) Figure France Market Value ($) and Growth Rate Forecast (2019-2024) Figure France Consumption and Growth Rate Forecast (2019-2024) Figure Italy Market Value ($) and Growth Rate Forecast (2019-2024) Figure Italy Consumption and Growth Rate Forecast (2019-2024) Figure Spain Market Value ($) and Growth Rate Forecast (2019-2024) Figure Spain Consumption and Growth Rate Forecast (2019-2024) Figure Russia Market Value ($) and Growth Rate Forecast (2019-2024) Figure Russia Consumption and Growth Rate Forecast (2019-2024) Figure Industry Resource/Technology/Labor Importance Analysis Table New Entrants SWOT Analysis Table New Project Analysis of Investment Recovery
  • PRICE
  • $3440
    $4500
    Buy Now

Our Clients